Edition:
United States

Huntsman Corp (HUN.N)

HUN.N on New York Stock Exchange

30.82USD
22 Nov 2017
Change (% chg)

$-0.18 (-0.58%)
Prev Close
$31.00
Open
$31.11
Day's High
$31.23
Day's Low
$30.60
Volume
517,077
Avg. Vol
852,305
52-wk High
$32.58
52-wk Low
$18.19

Chart for

About

Huntsman Corporation is a manufacturer of differentiated organic chemical products and of inorganic chemical products. The Company operates all of its businesses through its subsidiary, Huntsman International LLC (Huntsman International). The Company operates through five segments: Polyurethanes, Performance Products, Advanced... (more)

Overall

Beta: 2.90
Market Cap(Mil.): $7,397.05
Shares Outstanding(Mil.): 240.01
Dividend: 0.12
Yield (%): 1.62

Financials

  Industry Sector
P/E (TTM): -- 26.10 15.47
EPS (TTM): -- -- --
ROI: -- 7.89 11.81
ROE: -- 10.11 15.76

Clariant snubs review demand as showdown with White Tale looms

ZURICH Clariant on Friday rejected its largest shareholder White Tale's demand for an independent strategic review and three board seats, setting up a showdown with the activist investor that last month blocked its $20 billion merger with Huntsman .

1:43am EST

UPDATE 1-Clariant snubs review demand as showdown with White Tale looms

ZURICH, Nov 24 Clariant on Friday rejected its largest shareholder White Tale's demand for an independent strategic review and three board seats, setting up a showdown with the activist investor that last month blocked its $20 billion merger with Huntsman.

1:42am EST

Clariant snubs outside review, offers possible board seat

ZURICH, Nov 24 Clariant on Friday rejected its largest shareholder's demand for an independent strategic review and offered just one potential seat on the Swiss speciality chemicals maker's board, not the three places it wanted.

1:23am EST

Evonik not interested in Clariant in whole or part - source

DUESSELDORF, Germany, Nov 2 German specialty chemicals maker Evonik is currently not interested in buying Swiss peer Clariant or any of its parts, a person familiar with Evonik said, citing a lack of strategic fit and high prices the assets would command.

Nov 02 2017

Clariant CEO calls independent review 'premature' amid shareholder row

ZURICH Clariant Chief Executive Hariolf Kottmann said it would be "premature" to do an outside strategy review, a key demand of activist shareholders who derailed the Swiss chemical maker's planned $20 billion merger with U.S.-based Huntsman .

Oct 31 2017

Clariant post third-quarter beat amid row with biggest investor

ZURICH Clariant , the Swiss speciality chemicals maker whose top investor derailed its $20 billion merger with Huntsman , posted better-than-expected third-quarter sales and operating profit on Tuesday as acquisitions added to results.

Oct 31 2017

UPDATE 1-Clariant post Q3 beat amid row with biggest investor

ZURICH, Oct 31 Clariant, the Swiss speciality chemicals maker whose top investor derailed its $20 billion merger with Huntsman, posted better-than-expected third-quarter sales and operating profit on Tuesday as acquisitions added to results.

Oct 31 2017

Activist White Tale turns up pressure on Clariant

ZURICH The fight over chemicals company Clariant's future turned bitter on Monday as activists who thwarted a $20 billion merger with Huntsman threatened to call a shareholder meeting if they do not get three board seats and a strategy review.

Oct 30 2017

UPDATE 3-Activist White Tale turns up pressure on Clariant

* Clariant says open for talks, has duty to all shareholders (Adds comment from Clariant)

Oct 30 2017

Deals of the day- Mergers and acquisitions

Oct 27 The following bids, mergers, acquisitions and disposals were reported by 2010 GMT on Friday:

Oct 27 2017

Earnings vs. Estimates